Annual EBIT
-$191.79M$119.07M+38.30%
Summary
- Current Value
- As of today, EXAS annual EBIT is -$191.79M, up +38.30% on
- Historical Performance
- EXAS annual EBIT is up +73.70% over the past 3 years, and down -12.17% over the past 5 years
- All-Time High Comparison
- EXAS annual EBIT is currently -9316.14% below its historical high of -$2.04M set on
- 3-Year Low Comparison
- EXAS annual EBIT is +69.11% above its 3-year low of -$620.92M reached on an earlier date
- Sector Comparison
- EXAS annual EBIT is higher than 9.48% of companies in Healthcare sector
EBIT Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBIT | -$191.79M | +38.3% | +73.7% | -12.2% | -2195.5% | |
| Quarterly EBIT | $16.28M | +155.9% | +113.0% | +157.2% | +579.5% | |
| TTM EBIT | -$120.78M | +49.2% | +82.2% | +42.3% | -1130.0% | |
| Price | $102.11 | +80.2% | +73.6% | -22.1% | +1585.0% | |
| PE Ratio | - | – | – | – | – | |
| Annual Revenue | $2.76B | +10.4% | +56.1% | +214.8% | +10000.0% | |
| Annual EPS | -$5.59 | -392.9% | -60.7% | -772.9% | -1894.9% | |
| Annual EBITDA | $23.07M | +130.2% | +104.4% | +120.0% | +378.8% | |
| Annual Net Income | -$1.03B | -404.0% | -72.7% | -1124.9% | -10000.0% |
EBIT Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | -$191.79M | at high | |
| 5Y | -$157.40M | N/A | -21.9% |
| All | -$2.04M | -9316.1% |
EBIT Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$620.92M | N/A | +69.1% |
| 5Y | -$729.21M | +73.7% | |
| All | -$729.21M | +73.7% |
EBIT History
FAQ
What is the current annual EBIT of EXAS?
As of today, EXAS annual EBIT is -$191.79M
What is 1-year change in EXAS annual EBIT?
EXAS annual EBIT is up +38.30% year-over-year
What is 3-year change in EXAS annual EBIT?
EXAS annual EBIT is up +73.70% over the past 3 years
How far is EXAS annual EBIT from its all-time high?
EXAS annual EBIT is currently -9316.14% below its historical high of -$2.04M set on December 1, 1997
How does EXAS annual EBIT rank versus sector peers?
EXAS annual EBIT is higher than 9.48% of companies in Healthcare sector
When is EXAS next annual earnings release?
The next annual earnings release for EXAS is on
Quarterly EBIT
$16.28M$13.52M+489.54%
Summary
- Current Value
- As of today, EXAS quarterly EBIT is $16.28M, up +489.54% on
- Historical Performance
- EXAS quarterly EBIT is up +155.93% year-over-year, and up +113.05% over the past 3 years
- All-Time High Comparison
- EXAS quarterly EBIT is currently at its all-time high
- 3-Year Low Comparison
- EXAS quarterly EBIT is +114.23% above its 3-year low of -$114.45M reached on an earlier date
- Sector Comparison
- EXAS quarterly EBIT is higher than 83.84% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBIT | $16.28M | +489.5% | +155.9% | +113.0% | +157.2% | |
| Annual EBIT | -$191.79M | – | +38.3% | +73.7% | -12.2% | |
| TTM EBIT | -$120.78M | +27.3% | +49.2% | +82.2% | +42.3% | |
| Price | $102.11 | +71.7% | +80.2% | +73.6% | -22.1% | |
| PE Ratio | - | – | – | – | – | |
| Quarterly Revenue | $850.74M | +4.9% | +20.1% | +62.6% | +108.3% | |
| Quarterly EPS | -$0.10 | -1542.9% | +50.0% | +87.7% | +92.3% | |
| Quarterly EBITDA | $72.17M | +24.3% | +181.3% | +204.5% | +34.5% | |
| Quarterly Net Income | -$19.59M | -1553.5% | +48.8% | +86.8% | +90.3% |
Quarterly EBIT Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $16.28M | at high | |
| 3Y | $16.28M | at high | |
| 5Y | $16.28M | at high | |
| All | $16.28M | at high |
Quarterly EBIT Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$98.05M | +116.6% | |
| 3Y | -$114.45M | N/A | +114.2% |
| 5Y | -$290.24M | +105.6% | |
| All | -$290.24M | +105.6% |
Quarterly EBIT History
FAQ
What is the current quarterly EBIT of EXAS?
As of today, EXAS quarterly EBIT is $16.28M
What is EXAS quarterly EBIT most recent change?
EXAS quarterly EBIT was up +489.54% on September 30, 2025
What is 1-year change in EXAS quarterly EBIT?
EXAS quarterly EBIT is up +155.93% year-over-year
How far is EXAS quarterly EBIT from its all-time high?
EXAS quarterly EBIT is currently at its all-time high
How does EXAS quarterly EBIT rank versus sector peers?
EXAS quarterly EBIT is higher than 83.84% of companies in Healthcare sector
When is EXAS next earnings release?
The next earnings release for EXAS is on
TTM EBIT
-$120.78M$45.40M+27.32%
Summary
- Current Value
- As of today, EXAS TTM EBIT is -$120.78M, up +27.32% on
- Historical Performance
- EXAS TTM EBIT is up +49.22% year-over-year, and up +82.23% over the past 3 years
- All-Time High Comparison
- EXAS TTM EBIT vs all-time high is unknown
- 3-Year Low Comparison
- EXAS TTM EBIT is +78.84% above its 3-year low of -$570.78M reached on an earlier date
- Sector Comparison
- EXAS TTM EBIT is higher than 15.18% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBIT | -$120.78M | +27.3% | +49.2% | +82.2% | +42.3% | |
| Annual EBIT | -$191.79M | – | +38.3% | +73.7% | -12.2% | |
| Quarterly EBIT | $16.28M | +489.5% | +155.9% | +113.0% | +157.2% | |
| Price | $102.11 | +71.7% | +80.2% | +73.6% | -22.1% | |
| PE Ratio | - | – | – | – | – | |
| TTM Revenue | $3.08B | +4.8% | +14.5% | +53.7% | +133.4% | |
| TTM EPS | -$5.32 | +1.9% | -353.7% | -29.7% | -145.2% | |
| TTM EBITDA | $97.60M | +91.0% | +544.6% | +121.5% | +313.2% | |
| TTM Net Income | -$986.58M | +1.9% | -360.9% | -37.7% | -201.4% |
TTM EBIT Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$120.78M | at high | |
| 3Y | -$120.78M | at high | |
| 5Y | -$120.78M | at high | |
| All | $0.00 | N/A |
TTM EBIT Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$200.38M | N/A | +39.7% |
| 3Y | -$570.78M | N/A | +78.8% |
| 5Y | -$775.81M | +84.4% | |
| All | -$775.81M | +84.4% |
TTM EBIT History
FAQ
What is the current TTM EBIT of EXAS?
As of today, EXAS TTM EBIT is -$120.78M
What is EXAS TTM EBIT most recent change?
EXAS TTM EBIT was up +27.32% on September 30, 2025
What is 1-year change in EXAS TTM EBIT?
EXAS TTM EBIT is up +49.22% year-over-year
How far is EXAS TTM EBIT from its all-time high?
EXAS TTM EBIT vs all-time high is unknown
How does EXAS TTM EBIT rank versus sector peers?
EXAS TTM EBIT is higher than 15.18% of companies in Healthcare sector
When is EXAS next earnings release?
The next earnings release for EXAS is on
EBIT Formula
EBIT = Revenue − −
Data Sources & References
- EXAS Official Website www.exactsciences.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1124140/000112414025000091/0001124140-25-000091-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1124140/000112414025000020/0001124140-25-000020-index.htm
- EXAS Profile on Yahoo Finance finance.yahoo.com/quote/EXAS
- EXAS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/exas